8-K: Oscar Health Boosts 2026 Guidance

Oscar Health announced an improved full-year 2026 guidance for its Medical Loss Ratio and Earnings from Operations, alongside reaffirmations of revenue and SG&A expense targets.

Summary

• Oscar Health, Inc. is hosting its 2026 Investor Day on September 16, 2026, to discuss strategy and long-term financial targets.
• The company has improved its full-year 2026 guidance for Medical Loss Ratio to be between 81.0% and 82.0%, a 50 basis point improvement.
• Earnings from Operations guidance for full-year 2026 has been increased to between $600 million and $800 million, a $100 million increase.
• Full-year 2026 guidance for Total Revenue is reaffirmed between $18.7 billion and $19.0 billion.
• Full-year 2026 guidance for SG&A Expense Ratio is reaffirmed between 15.6% and 16.1%.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive update, with improved guidance for key financial metrics indicating strong operational execution and a favorable outlook.

Positives

• Improved Medical Loss Ratio guidance to 81.0%-82.0% (50 basis point improvement).
• Increased Earnings from Operations guidance to $600 million $800 million (a $100 million increase).
• Reaffirmed Total Revenue guidance of $18.7 billion $19.0 billion.
• Reaffirmed SG&A Expense Ratio guidance of 15.6% 16.1%.

Risks

• Forward-looking statements are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond the company's control.
• Actual results could differ materially from those indicated in forward-looking statements due to factors detailed in the company's Form 10-K for the year ended December 31, 2025, and other SEC filings.

Future Outlook

The company has improved its full-year 2026 guidance for Medical Loss Ratio and Earnings from Operations, while reaffirming its guidance for Total Revenue and SG&A Expense Ratio, indicating confidence in its strategic direction and operational performance.

Industry Context

StockSavvy.ai notes that improving Medical Loss Ratios and increasing Earnings from Operations are key indicators of financial health and operational efficiency in the health insurance sector, especially amidst evolving regulatory and market conditions.

Stakeholder Impact

• Shareholders may see increased confidence due to improved financial guidance.
• Investors will receive updated information on strategy and financial targets at the Investor Day.

Next Steps

• Host 2026 Investor Day on September 16, 2026.
• Discuss strategy and long-term financial targets at Investor Day.
• Discuss financial performance and outlook at Investor Day.
• Webcast of the presentation and associated materials will be available on the investor relations website.
• Webcast will be archived on the investor relations website for 90 days following September 16, 2026.

Key Dates

Recommendation

The improved guidance is positive, but the filing is primarily an update and reaffirmation of existing targets, with no significant new strategic initiatives or material changes beyond guidance adjustments. A hold recommendation reflects the positive but not transformative nature of the announcement.

Keywords

Investor Day, Financial Guidance, Medical Loss Ratio, Earnings from Operations, Revenue, SG&A Expense Ratio, Healthcare, Health Insurance